Introduction {#sec1}
============

Vitamin B-12 and folate are essential micronutrients and their deficiencies have public health implications ([@bib1]--[@bib3]). In regions where consumption of animal-source or fortified foods are not common or prohibitively expensive, individuals may be at risk of vitamin B-12 deficiency ([@bib4]). Malabsorption through pernicious anemia and atrophic gastritis achlorhydria, among other factors, also contributes to vitamin B-12 deficiency ([@bib5]). Adequate folate status is of particular importance among women of reproductive age (WRA) because low-folate status in early pregnancy increases the risk of neural tube defects among offspring ([@bib6]). However, despite the importance of these nutrients, their measurement is generally not included in population surveys, and data gaps preclude global estimates of vitamin B-12 and folate deficiencies ([@bib1], [@bib3], [@bib9]). For folate in particular, data availability is complicated by the fact that there are large differences in folate assays due to different assay approaches (e.g., microbiological, immunoassay, and chromatography-based), analytes (e.g., total compared with major circulating types of folate), and antibodies used for immunoassay approaches, making it difficult to choose the correct thresholds to define deficiency in many situations ([@bib10]--[@bib12]).

In addition, there is limited evidence on the question of whether folate or vitamin B-12 may be influenced by inflammation and if this should be taken into account when estimating the prevalence of deficiency ([@bib13]--[@bib15]). Inflammation is common in many settings where nutritional assessment occurs and is assessed frequently in large surveys by measuring acute-phase proteins C-reactive protein (CRP) and α1-acid glycoprotein (AGP) ([@bib16]). When assessing the nutritional status of a population using biomarker surveys it is critical to understand the interaction of inflammation with the biomarkers of interest. Recent findings from the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project demonstrated relations between biomarkers of inflammation and biomarkers of both iron and vitamin A and recommended methods for adjustment in settings of inflammation ([@bib17]--[@bib21]). However, there has been limited systematic exploration of the potential role of inflammation on biomarkers of vitamin B-12 and folate in large-scale surveys. For adjustments to be recommended, there should be evidence of biological plausibility that inflammation is acting independently of dietary intake and consistency in relations between micronutrient biomarkers and inflammation across a variety of contexts. A review by Tomkins describes a reduction in serum folate during acute inflammation, while RBC folate appears to be more stable (reflecting mean folate status during proceeding ∼120 days) and less affected by acute inflammatory responses ([@bib15]). McMillan et al. report an inverse relation with vitamin B-12 and CRP in clinical settings ([@bib22]). However, there remains conflicting evidence surrounding the impact of inflammation on biomarkers of these nutrients ([@bib13]--[@bib15], [@bib23], [@bib24]). To address these gaps in our understanding our objective was to examine if inflammation is correlated with biomarkers of vitamin B-12 and folate status among WRA and preschool children (PSC) in the BRINDA project.

Methods {#sec2}
=======

We used cross-sectional survey data from the BRINDA project ([www.BRINDA-nutrition.org](http://www.BRINDA-nutrition.org)). A description of the methods used to identify data sets, define inclusion and exclusion criteria, and manage the BRINDA database has been previously reported ([@bib19], [@bib21]). In brief, we included nationally representative surveys in PSC (aged 6--59 mo), nonpregnant WRA (15--49 yr), or both where data were available for ≥1 biomarker of inflammation (CRP, AGP, or both) and ≥1 biomarker for vitamin B-12 or folate (serum or RBC folate) (**[Supplemental Figure 1](#sup1){ref-type="supplementary-material"}**).

Laboratory analysis {#sec2-1}
-------------------

Venous blood was obtained from all survey participants, with the exception of participants from Mongolia, from whom there was a combination of capillary and venous blood samples. Plasma and serum samples were stored at −20°C until analysis in all participating surveys. Laboratory methods used for analysis of CRP, AGP, vitamin B-12, serum folate, and RBC folate are summarized in **[Supplemental Table 1](#sup1){ref-type="supplementary-material"}** for each survey. Given large discrepancies between commercially available folate assays ([@bib11]), we did not pool folate data across surveys for meta-analyses. Differences in vitamin B-12 results among assays also exist ([@bib25]); thus, we chose not to pool vitamin B-12 results across surveys either. Additionally, we did not report on estimated prevalence of deficiencies, given the wide variation in laboratory methods. Inflammation was defined according to a CRP concentration \>5 mg/L or an AGP concentration \>1 g/L ([@bib26]). Methods for CRP and AGP assessment are mostly consistent across assays due to availability of reference materials and external quality assessment programs ([@bib27]--[@bib31]). Malaria was measured in 3 WRA and 1 PSC surveys. Malaria infection was defined as either positive or negative based on rapid diagnostic kit results.

Statistical analysis {#sec2-2}
--------------------

All statistical analyses were performed using SAS 9.4 (SAS Institute). All analyses took into account complex survey design effects, including cluster, strata, and biomarker-specific sampling weights, unless otherwise specified. The weighted Spearman\'s correlation coefficients were determined by first calculating the ranks of inflammation (CRP or AGP) and vitamin B-12 or folate (serum or RBC) within each survey and then estimating the weighted Pearson\'s correlation between the rank variables. Unweighted correlation analyses were also conducted and produced similar findings (data not shown). The geometric means and 95% CIs of vitamin B-12 and folate measure were plotted by CRP and AGP decile within each survey to investigate if there was a linear relation between inflammation and vitamin B-12 or folate, similar to prior BRINDA publications ([@bib19]). Results were considered significant at *P* \< 0.05. Analyses were conducted separately for each survey.

Sensitivity analyses were conducted with surveys to examine the potential role of malaria infection, because folate is required for parasite replication. To investigate the interaction of malaria infection with nutrient biomarkers, we stratified individuals by malaria status in the 3 surveys that contained individual-level malaria information, compared stratified correlations, and tested for interactions. Although we also intended to explore the role of fasting, insufficient individual-level data on fasting data to test the interaction of fasting were available; only 1 survey had both fasted and nonfasted subjects, and in this survey few subjects were fasted (*n* = 13) (data not shown).

Results {#sec3}
=======

Participant characteristics {#sec3-1}
---------------------------

Our study sample was restricted to participants with no missing values for either vitamin B-12, serum folate, or RBC folate, and with data available for CRP or AGP, or both. On the basis of these criteria, data on WRA were available from 14 surveys, and on PSC in 8 surveys, representing 32,588 WRA and 8256 PSC. Vitamin B-12 data were available from 13 surveys in WRA (*n* = 29,552) and 5 surveys in PSC (*n* = 5726). For serum folate, 12 surveys from WRA (*n* = 30,900) and 8 surveys from PSC (*n* = 8132) were available. RBC folate was measured in only 3 surveys in WRA (*n* = 12,048) and 2 surveys in PSC (*n* = 3318). Mean age among PSC ranged from 20.1 mo in Mongolia to 41.8 mo in Mexico ([**Table 1**](#tbl1){ref-type="table"}). Among WRA, mean age ranged from 27.1 yr in Cameroon to 34.7 yr in Mexico. The prevalence of elevated CRP ranged from 6.0% to 38.4% in PSC and from 5.3% to 27.9% in WRA. The prevalence of elevated AGP ranged from 24.6% to 39.8% in PSC and from 5.5% to 33.6% in WRA. [**Table 2**](#tbl2){ref-type="table"} reports median and IQRs for vitamin B-12, serum folate, and RBC folate.

###### 

Age and inflammation of PSC and nonpregnant WRA, BRINDA project[^1^](#tb1fn1){ref-type="table-fn"}

                                                     CRP              AGP                                  
  ----------------------- ------ ------------------- ---------------- ------------------- ---------------- -------------------
  PSC                                                                                                      
   Cambodia, 2014         646    36.4 (35.3, 37.5)   2.2 (1.5, 3)     10.1 (7.3, 12.9)    1.1 (1, 1.3)     36 (29.4, 42.6)
   Cameroon, 2009         362    32.3 (30.9, 33.8)   5.6 (4.7, 6.4)   38.4 (31.3, 45.4)   1 (0.9, 1)       39.8 (32.1, 47.4)
   Ecuador, 2012          2019   30.8 (29.5, 32.2)   4 (3.5, 4.5)     12.5 (10.1, 14.9)   ---              ---
   Mexico, 2006           974    41.8 (40.6, 42.9)   2.2 (1.7, 2.6)   10.3 (7.6, 13)      ---              ---
   Mexico, 2012           2538   39.1 (38.5, 39.7)   2.4 (2, 2.9)     11.7 (9.3, 14.1)                     
   Mongolia, 2006         228    20.1 (20.1, 21.3)                                        0.8 (0.8, 0.9)   24.6 (19.0, 30.2)
   USA, 2006              1315   36.7 (35.6, 37.8)   1.4 (1.1, 1.7)   6 (4.5, 7.5)        ---              ---
   Vietnam, 2010          174    38.5 (36.9, 40.1)   2.4 (1.4, 3.5)   12.6 (7.8, 17.5)    ---              ---
  WRA                                                                                                      
   Azerbaijan, 2013       2611   32.1 (31.6, 32.5)   2.8 (2.5, 3)     13.2 (11.2, 15.1)   0.9 (0.9, 0.9)   31.7 (29.3, 34)
   Bangladesh, 2012       863    30 (28.8, 31.1)     1.5 (1.2, 1.8)   5.3 (2.8, 7.8)      0.7 (0.7, 0.8)   13.2 (9.1, 17.3)
   Cambodia, 2014         700    30.2 (29.4, 30.9)   2 (1.6, 2.3)     9.5 (7.2, 11.9)     1 (0.9, 1.1)     33.6 (24.9, 42.3)
   Cameroon, 2009         335    27.1 (26.2, 28)     2.7 (2.2, 3.1)   15.8 (11.4, 20.3)   0.8 (0.7, 0.8)   5.5 (2.6, 8.4)
   Colombia, 2010         611    29.1 (28.1, 30.2)   5.4 (4.3, 6.5)   26.5 (21.9, 31.2)   ---              ---
   Côte d\'Ivoire, 2007   792    27.6 (26.9, 28.3)   3.8 (3.2, 4.3)   19.7 (16.5, 22.9)   0.9 (0.8, 0.9)   26.5 (22.9, 30)
   Ecuador, 2012          8118   30.3 (29.8, 30.7)   4.1 (3.9, 4.3)   17.4 (16, 18.8)     ---              ---
   Georgia, 2009          407    34.2 (33.2, 35.3)   5.2 (4.3, 6.2)   27.9 (23.3, 32.5)   ---              ---
   Malawi, 2016           767    28.4 (27.7, 29)     2.4 (1.7, 3.1)   7.6 (5.3, 9.9)      0.7 (0.6, 0.7)   11.1 (8, 14.3)
   Mexico, 2012           3608   34.7 (34.4, 35.1)   3.7 (3.4, 4)     20.8 (18.2, 23.3)   ---              ---
   Pakistan, 2011         8307   30.8 (30.6, 30.9)   2.7 (2.4, 2.9)   11.6 (10.7, 12.5)   0.8 (0.8, 0.9)   23.9 (22.5, 25.3)
   UK, 2014               895    34.4 (33.5, 35.3)   3.3 (3, 3.7)     16 (12.7, 19.2)     ---              ---
   USA, 2006              3197   33.5 (33, 34)       4.4 (4, 4.8)     25.6 (23.5, 27.8)   ---              ---
   Vietnam, 2010          1377   32.2 (31.6, 32.7)   1.8 (1.6, 2.1)   6.5 (5.3, 7.7)      ---              ---

AGP, α1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; PSC, preschool children; WRA, women of reproductive age.

Age values are shown in months for preschool children and years for women of reproductive age. Mongolia did not apply complex survey design.

###### 

Vitamin B-12, serum folate, and RBC folate in PSC and nonpregnant WRA: BRINDA project[^1^](#tb2fn1){ref-type="table-fn"}

  Survey, year            Vitamin B-12, *n*   Vitamin B-12, median (25th, 75th percentile), pmol/L   Serum folate sample size, *n*   Serum folate, median (25th, 75th percentile), pmol/L   RBC folate, *n*   RBC folate median (25th, 75th percentile), nmol/L
  ----------------------- ------------------- ------------------------------------------------------ ------------------------------- ------------------------------------------------------ ----------------- ---------------------------------------------------
  PSC                                                                                                                                                                                                         
   Cambodia, 2014         645                 413.3 (312.3, 597.8)                                   646                             20.9 (14.8, 29.2)                                      ---               ---
   Cameroon, 2009         361                 312.1 (195.6, 493.2)                                   362                             21.2 (14.4, 30.1)                                      ---               ---
   Ecuador, 2012          ---                 ---                                                    2019                            57.4 (42.6, 77.3)                                      2019              1029.2 (786.4, 1325.6)
   Mexico, 2006           931                 461.1 (315.6, 642.7)                                   940                             28.7 (20.4, 37.7)                                      ---               ---
   Mexico, 2012           2527                526.4 (381.5, 693.4)                                   2496                            35.9 (32.0, 38.8)                                      ---               ---
   Mongolia, 2006         ---                 ---                                                    228                             17.7 (12.3, 24.6)                                                        ---
   USA, 2006              1262                606.7 (462.8, 796.6)                                   1267                            35.8 (25.0, 44.7)                                      1299              597.6 (498.9, 729.2)
   Vietnam, 2010          ---                 ---                                                    174                             22.0 (17.3, 29.1)                                                        ---
  WRA                                                                                                                                                                                                         
   Azerbaijan, 2013       1317                272.2 (182.7, 345.7)                                   2551                            10.9 (9.4, 13.0)                                       ---               ---
   Bangladesh, 2012       863                 311.8 (229.7, 413.3)                                   847                             10.6 (8.6, 13.9)                                       ---               ---
   Cambodia, 2014         700                 498.3 (359.6, 690.9)                                   699                             13.8 (10.6, 18.7)                                      ---               ---
   Cameroon, 2009         335                 343.7 (208.8, 547.6)                                   335                             17.8 (11.5, 26.4)                                      ---               ---
   Colombia, 2010         611                 275.7 (196.8, 473.9)                                   ---                             ---                                                    ---               ---
   Côte d\'Ivoire, 2007   400                 300.9 (187.9, 447.6)                                   792                             3.6 (2.1, 6.5)                                         ---               ---
   Ecuador, 2012          8116                401.5 (302.7, 553.3)                                   8118                            32.3 (22.9, 45.3)                                      8118              895.5 (699.4, 1182.7)
   Georgia, 2009          ---                 ---                                                    407                             5.2 (3.1, 8.4)                                         ---               ---
   Malawi, 2012           765                 252.7 (180.8, 375.6)                                   755                             18.0 (11.3, 29.1)                                      752               492.8 (352.0, 668.1)
   Mexico, 2012           3608                366.1 (279.6, 530.9)                                   3608                            29.3 (22.4, 33.0)                                      ---               ---
   Pakistan, 2011         8287                141.1 (62.8, 291.2)                                    8257                            8.7 (2.8, 40.3)                                        ---               ---
   UK, 2014               895                 243.6 (197.7, 306.3)                                   ---                             ---                                                    ---               ---
   USA, 2006              3166                328.0 (252.7, 436.5)                                   3186                            24.9 (18.3, 32.8)                                      3178              562.5 (448.5, 707.6)
   Vietnam, 2010          489                 552.5 (329.0, 881.0)                                   1345                            16.8 (12.5, 22.7)                                      ---               ---

Mongolia did not apply a complex survey design. BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; PSC, preschool children; WRA, women of reproductive age.

Relation between vitamin B-12 or folate biomarkers and inflammation {#sec3-2}
-------------------------------------------------------------------

Strong positive correlations between CRP and AGP were found across data sets that had both inflammation biomarkers (correlation coefficient ranged from 0.2 to 0.7, *P* \< 0.0001, data not shown). Weak and inconsistent correlation coefficients between vitamin B-12 and inflammation biomarkers (CRP and AGP) were observed for WRA and PSC ([**Table 3**](#tbl3){ref-type="table"}). For WRA, 3 surveys reported significant positive associations between vitamin B-12 and CRP, 3 surveys reported significant negative associations, and in 7 surveys, the correlations were nonsignificant. Correlations between vitamin B-12 and AGP were similar, with 3 surveys reporting significant positive associations and 4 surveys reporting nonsignificant associations. Likewise, among PSC there were no clear patterns of associations for vitamin B-12 and CRP or AGP, with correlation coefficients ranging from 0.12 to −0.07.

###### 

Weighted Spearman correlations between vitamin B-12 and CRP and AGP in PSC and nonpregnant WRA, BRINDA project[^1^](#tb3fn1){ref-type="table-fn"}

                                 Vitamin B-12 and CRP correlation             Vitamin B-12 and AGP correlation           
  ----------------------- ------ ---------------------------------- --------- ---------------------------------- ------- -------
  PSC                                                                                                                    
   Cambodia, 2014         645    −0.01                              0.752     645                                −0.07   0.283
   Cameroon, 2009         361    0.00                               0.967     361                                −0.06   0.311
   Mexico, 2006           931    0.00                               0.946                                        ---     ---
   Mexico, 2012           2527   0.05                               0.146                                        ---     ---
   USA, 2006              1262   0.12                               0.001                                        ---     ---
  WRA                                                                                                                    
   Azerbaijan, 2013       1317   −0.02                              0.629     1317                               −0.02   0.586
   Bangladesh, 2012       862    0.02                               0.408     863                                0.14    0.001
   Cambodia, 2014         700    −0.01                              0.843     700                                −0.05   0.350
   Cameroon, 2009         335    0.01                               0.802     335                                −0.03   0.566
   Colombia, 2010         611    −0.25                              0.307                                        ---     ---
   Côte d\'Ivoire, 2007   400    0.16                               0.008     400                                0.14    0.005
   Ecuador, 2012          8116   0.00                               0.791                                        ---     ---
   Malawi, 2016           765    0.01                               0.744     765                                0.00    0.958
   Mexico, 2012           3608   0.10                               0.001                                        ---     ---
   Pakistan, 2011         8287   0.04                               0.017     6509                               0.04    0.034
   UK, 2014               895    −0.11                              0.020                                        ---     ---
   USA, 2006              3166   −0.08                              \<0.001                                      ---     ---
   Vietnam, 2010          489    −0.09                              0.032                                        ---     ---

*P* value was calculated from a *t* test in a regression model that took into account complex sampling (cluster, strata, and sampling weight). AGP, α1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; PSC, preschool children; WRA, women of reproductive age.

[**Table 4**](#tbl4){ref-type="table"} presents the summary of the correlations between serum folate and CRP and AGP among WRA and PSC. For WRA, the correlations between serum folate and CRP ranged from −0.13 to 0.08, with a significant positive correlation in 1 survey, significant negative correlations in 4 surveys, and nonsignificant results in 7 surveys. For AGP, correlations with serum folate in WRA ranged from −0.12 to 0.02, with significant negative correlations in 4 surveys and nonsignificant results in 3 surveys. Results were similar among PSC, with the majority of surveys reporting nonsignificant correlations between serum folate and CRP and AGP. Only 1 survey showed a significant positive correlation with serum folate and CRP, and 1 showed a significant negative correlation with serum folate and AGP.

###### 

Weighted Spearman correlations between serum folate and CRP and AGP in PSC and nonpregnant WRA, BRINDA project[^1^](#tb4fn1){ref-type="table-fn"}

                                 Serum folate and CRP correlation             Serum folate and AGP correlation           
  ----------------------- ------ ---------------------------------- --------- ---------------------------------- ------- ---------
  PSC                                                                                                                    
   Cambodia, 2014         646    −0.05                              0.319     646                                −0.21   \<0.001
   Cameroon, 2009         362    0.00                               0.948     362                                −0.04   0.555
   Ecuador, 2012          2019   0.05                               0.005                                        ---     ---
   Mexico, 2006           940    0.01                               0.845                                        ---     ---
   Mexico, 2012           2496   −0.04                              0.246                                        ---     ---
   Mongolia, 2006                ---                                ---       228                                −0.07   0.292
   USA, 2006              1267   −0.06                              0.100                                        ---     ---
   Vietnam, 2010          174    −0.06                              0.506     ---                                ---     ---
  WRA                                                                                                                    
   Azerbaijan, 2013       2551   0.07                               0.008     2551                               0.00    0.992
   Bangladesh, 2012       846    −0.09                              0.091     847                                −0.12   0.028
   Cambodia, 2014         699    −0.07                              0.198     699                                −0.12   0.032
   Cameroon, 2009         335    −0.06                              0.329     335                                0.02    0.641
   Côte d\'Ivoire, 2007   792    −0.09                              0.003     792                                0.00    0.909
   Ecuador, 2012          8118   −0.12                              \<0.001                                      ---     ---
   Georgia, 2009          407    0.08                               0.088                                        ---     ---
   Malawi, 2016           755    −0.13                              0.013     755                                −0.11   0.026
   Mexico, 2012           3608   0.03                               0.242                                        ---     ---
   Pakistan, 2011         7819   0.02                               0.135     6481                               −0.04   0.017
   USA, 2006              3186   −0.07                              0.003                                        ---     ---
   Vietnam, 2010          1345   0.02                               0.402                                        ---     ---

*P* value was calculated from a *t* test in a regression model that took into account complex sampling (cluster, strata, and sampling weight). Mongolia did not apply a complex survey design. AGP, α1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; PSC, preschool children; WRA, women of reproductive age.

Survey data that contained both RBC folate and markers of inflammation were limited ([**Table 5**](#tbl5){ref-type="table"}). Among the 3 surveys that assessed RBC among WRA, 2 resulted in weak significant positive correlations with CRP, and in 1 survey the relation was nonsignificant. Only 1 survey had data available on RBC folate and AGP, and in this survey the correlations were nonsignificant. Among PSC, data were available for 2 surveys and there was a weak significant negative correlation (−0.07) in survey results from 1 country and nonsignificant results in the second survey. Data were not available to assess correlations between RBC folate and AGP in PSC.

###### 

Weighted Spearman correlations between RBC folate and CRP and AGP in PSC and non-pregnant WRA, BRINDA project[^1^](#tb5fn1){ref-type="table-fn"}

                          RBC folate and CRP correlation           RBC folate and AGP correlation           
  ---------------- ------ -------------------------------- ------- -------------------------------- ------- -------
  PSC                                                                                                       
   Ecuador, 2012   2019   −0.07                            0.045                                    ---     ---
   USA, 2006       1299   −0.01                            0.833                                    ---     ---
  WRA                                                                                                       
   Ecuador, 2012   8118   0.05                             0.006                                    ---     ---
   Malawi, 2016    752    −0.06                            0.283   752                              −0.04   0.432
   USA, 2006       3178   0.08                             0.003                                    ---     ---

*P* values were calculated from a *t* test in a regression model that took into account complex sampling (cluster, strata, and sampling weight). AGP, α1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; PSC, preschool children; WRA, women of reproductive age.

The relations between the mean nutrient concentrations for vitamin B-12, serum folate, and RBC folate and inflammation deciles (CRP and AGP) were highly variable, with no clear pattern of association across the surveys (**[Supplemental Figures 2--12](#sup1){ref-type="supplementary-material"}**). To examine the potential role of malaria status on the aforementioned correlations, we conducted a stratified analysis and tested for interaction among the 3 surveys with individual data on malaria and inflammation and vitamin B-12, serum folate, or RBC folate (**[Supplemental Table 2](#sup1){ref-type="supplementary-material"}**). For vitamin B-12, associations with CRP remained weak regardless of malaria status and there was no evidence of interaction in WRA or PSC. For vitamin B-12 and AGP, there was a significant interaction among WRA in Malawi; women who were infected by malaria had a negative correlation (−0.21), whereas those without malaria had a positive association (0.05). However, results were nonsignificant in Côte d\'Ivoire and Cameroon. For serum folate and RBC folate there was no evidence of interaction with CRP or AGP in either WRA or PSC.

Discussion {#sec4}
==========

In our large, multicountry analysis of approximately 32,000 WRA and 8000 PSC, there was no clear pattern of association between inflammation (CRP or AGP) and vitamin B-12 and serum or RBC folate among WRA and PSC. Correlations were weak (most \<0.2) and of various levels of significance and direction (some positive and some negative). In addition, there was no clear pattern of association between inflammation deciles (CRP and AGP) and micronutrient biomarkers across the surveys. Thus, current data do not support the need to adjust these biomarkers for inflammation in population-based surveys. However, there remain important data gaps, in particular for RBC folate, AGP, and child-level data, that may merit re-examination when further data are available.

The weak and inconsistent correlations among the 16 surveys included in the BRINDA data sets are in alignment with the conflicting existing research on this topic ([@bib13]--[@bib15], [@bib23], [@bib24], [@bib32], [@bib33]). While deciding when and if to adjust a nutrient biomarker for inflammation, it is important to first review if there is clearly a biological rationale to justify adjustment. For example, there is a strong biological rationale for adjusting serum ferritin, which itself is an acute-phase response protein, for inflammation ([@bib18]). There is evidence, although inconsistent, that inflammation could affect folate status through enteric malabsorption, increasing folate requirements to support erythropoiesis in the presence of repeated malarial infections, among other mechanisms that remain not fully understood ([@bib24], [@bib34]). Conversely, folate insufficiency may affect inflammation through multiple mechanisms ([@bib24], [@bib35]--[@bib37]). For example, low folate may impair methionine synthase activity, leading to hyperhomocysteinemia and damage to endothelial cells ([@bib24], [@bib35]--[@bib37]). Likewise, there is some evidence of a bidirectional relation with vitamin B-12 and inflammation or infection through the following potential mechanisms: chronic inflammatory conditions such as hepatitis may increase serum transcobalamins and vitamin B-12, altered serum concentrations may result from cytolysis of liver cells and impaired clearance as a result of liver diseases, and infections may impair absorption through reduced secretion of gastric acid or competition for vitamin B-12, among other potential mechanisms in which there is limited human evidence ([@bib24], [@bib38], [@bib39]). It is important to note that many of these potential mechanisms may explain intermediate pathways between inflammation and folate or vitamin B-12 status. However, there is not a consensus on how inflammation may impact folate or vitamin B-12 concentrations. Thus, even if statistically significant associations exist between micronutrient and inflammation indicators within a given survey, at this time there does not appear to be a clear biological rationale to justify adjustment.

This is one of the largest studies to date to examine correlations between inflammation biomarkers and serum vitamin B-12, serum folate, and RBC folate; however, there remain critical gaps in our understanding due to varying laboratory methods and data availability that merit further examination and future research. The relations between nutrition biomarkers and inflammation may vary based on the severity of deficiency and the underlying prevalence of inflammation. However, in our analysis there were no clear patterns of association. For example, despite differences in elevated CRP in Cameroon (38%) and Mexico, 2006 (10%), there were very similar correlations between vitamin B-12 and CRP (*r* = 0.00, *P* = 0.97; *r* = 0.00, *P* = 9.5) and serum folate (*r* = 0.00, *P* = 0.95; *r* = 0.01, *P* = 0.85), respectively. We were not able to pool the data or compare vitamin blood concentrations across surveys due to method differences across surveys ([@bib11], [@bib25], [@bib40]). Large differences in results have been reported among assays, 1.5- to 6-fold differences for serum folate and 8- to 40-fold differences in RBC folate ([@bib11]). Although differences in vitamin B-12 results among assays are smaller (up to ∼2-fold) assay errors and, particularly, an overestimation of low vitamin B-12 concentrations by some assays have been reported ([@bib25]), we therefore chose not to pool vitamin B-12 results across surveys either. Pooling of biomarker data from these surveys would not be appropriate and would further complicate interpretation of correlations. Laboratory assays for numerous nutritional biomarkers, including folate and vitamin B-12, require standardization and the use of certified reference materials to verify method accuracy and to ensure better comparability of data across laboratories and over time ([@bib36], [@bib41]). As this is a secondary analysis of existing data, we are limited by the micronutrient and inflammation biomarkers data available in the data sets. Our analysis was particularly limited by a lack of information about CRP in the data sets, for which limits of detection (LODs) and limits of quantification (LOQs) vary widely across assays, and for which there may be high proportions of undetectable/unquantifiable observations. In a sensitivity analysis, surveys conducted at a single laboratory with a known CRP LOD of 0.5 mg/L were assigned a CRP value of 0.25 mg/L, and our correlation analysis was rerun. As shown in **[Supplemental Tables 3--5](#sup1){ref-type="supplementary-material"}**, the results of this sensitivity analysis yielded similar results to the primary analysis. Unfortunately, information on the LODs and LOQs was not available for all surveys, and future work should investigate how different approaches for handling values below the LOD/LOQ may influence interpretation of biomarkers. Data on dietary intake, availability of fortified foods, and morbidity symptoms, which could explain reasons for deficiency and causes of inflammation, would also be useful for exploring contextual features that were included in the surveys. Few surveys had individual-level malaria or fasting data available, which precludes us from being able to determine the potential influence of these factors on our results. We do not have data on other indicators of folate and vitamin B-12 status (e.g., total homocysteine or methylmalonic acid) or other inflammation biomarkers (e.g., TNF-α or albumin). For example, previous research in Saudi Arabia demonstrated a significant inverse association between vitamin B-12 and TNF-α among adults but not children ([@bib42]).

Our findings are limited to those from population-based surveys and should not be generalized to the clinical setting where individual patient data are interpreted. Prior clinical-based studies have examined the changes in nutrient levels following surgery and found mixed effects ([@bib14], [@bib43]). The current findings are also limited to WRA and PSC, and future work is needed to confirm these findings in pregnant women, men, and infants. Lastly, the cross-sectional nature of the surveys included in the present study preclude us from determining causality. The potential for reverse causality cannot be ruled out, given that micronutrients may have proinflammatory or anti-inflammatory effects.

The key strength of this study is the large and diverse data set for analysis. We had data on 32,588 WRA and 8256 PSC from across the globe. This diversity was critical for providing a more comprehensive picture and also suggests caution should be taken before making recommendations from one data set alone. With our large sample sizes, we are more likely to detect statistically significant results. For example, while the relation between CRP and vitamin B-12 was statistically significant in Ecuador (*n* = 8118), the correlation was only 0.03 and unlikely to be of biological significance. Given the limitations of this work, we were conservative in our analysis and interpretation of the findings. This study highlights the need to establish a clear biological rationale and consistent correlations across countries and populations before applying the BRINDA approach to adjust nutrient biomarkers for inflammation.

In conclusion, our current analysis of 16 nationally representative surveys does not support the need to adjust vitamin B-12, serum folate, or RBC folate for inflammation in population-based surveys of women of reproductive age or preschool children. There is a need to reexamine this question as progress is made in standardizing laboratory methods across regions and as data with new or more sensitive biomarkers become available.
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